AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30448343 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 30449018 — intervention group
Group type: EXPERIMENTAL
Intervention: Endogenous hyperinsulinaemic hypoglycaemia (EHH)
Number of subjects: 54
Study 30449033 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound-guided injection of cyanoacrylate (CYA) and a less-expensive coil
Number of subjects: 30
Study 30449509 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 20
Study 30449509 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 20
Study 30449509 — intervention group
Group type: COMPARATOR
Intervention: Both LSG and LRYGB
Number of subjects: 20
Study 30449647 — intervention group
Group type: EXPERIMENTAL
Intervention: Care coordinator services
Number of subjects: 2061
Study 30449712 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM)
Number of subjects: 203
Study 30449712 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure Therapy (PE)
Number of subjects: 203
Study 30449712 — intervention group
Group type: COMPARATOR
Intervention: PTSD Health Education (HE)
Number of subjects: 203
Study 30450044 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS and cognitive intervention
Number of subjects: 100
Study 30450044 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 100
Study 30450044 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive intervention
Number of subjects: 100
Study 30450044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 30450355 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 30450469 — intervention group
Group type: EXPERIMENTAL
Intervention: Proenkephalin A 119-159 (Penkid)
Number of subjects: 583
Study 30450469 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 583
Study 30450553 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular global longitudinal strain assessment
Number of subjects: 143
Study 30450591 — intervention group
Group type: EXPERIMENTAL
Intervention: Aurora B kinase inhibitor BI 811283 in combination with cytarabine
Number of subjects: 0
Study 30450591 — intervention group
Group type: COMPARATOR
Intervention: Cytarabine alone
Number of subjects: 0
Study 30451655 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) 50 mg once weekly for 24 weeks
Number of subjects: 187
Study 30451741 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (EVR)
Number of subjects: 0
Study 30451741 — intervention group
Group type: COMPARATOR
Intervention: Rapamycin (RAPA)
Number of subjects: 0
Study 30451764 — intervention group
Group type: EXPERIMENTAL
Intervention: Texture analysis of T2-weighted magnetic resonance images
Number of subjects: 114
Study 30452076 — intervention group
Group type: EXPERIMENTAL
Intervention: Contour 3D annuloplasty ring
Number of subjects: 112
Study 30452500 — intervention group
Group type: EXPERIMENTAL
Intervention: No ROP prior to hospital discharge
Number of subjects: 1257
Study 30452500 — intervention group
Group type: EXPERIMENTAL
Intervention: ROP treatment at 32 weeks' postmenstrual age
Number of subjects: 1257
Study 30452500 — intervention group
Group type: EXPERIMENTAL
Intervention: ROP treatment at 33 weeks' postmenstrual age
Number of subjects: 1257
Study 30452500 — intervention group
Group type: EXPERIMENTAL
Intervention: No ROP at hospital discharge for infants 27 to 33 weeks' gestational age
Number of subjects: 1257
Study 30452500 — intervention group
Group type: COMPARATOR
Intervention: No ROP at hospital discharge for infants less than 27 weeks' gestational age
Number of subjects: 1257
Study 30452500 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up of infants without ROP by 37 weeks' postmenstrual age
Number of subjects: 1257
Study 30452500 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger birth weight and higher gestational age
Number of subjects: 1257
Study 30452666 — intervention group
Group type: EXPERIMENTAL
Intervention: VSV-EBOV vaccine (single-dose regimen)
Number of subjects: 0
Study 30452963 — intervention group
Group type: COMPARATOR
Intervention: Symptom duration < 2 years
Number of subjects: 0
Study 30452963 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom duration ≥ 2 years
Number of subjects: 0
Study 30454733 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometriosis
Number of subjects: 567
Study 30454753 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction and maintenance immunosuppression
Number of subjects: 0
Study 30454872 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmyeloablative allogeneic hematopoietic cell transplantation (HCT)
Number of subjects: 0
Study 30454872 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioimmunotherapy
Number of subjects: 0
Study 30455089 — intervention group
Group type: EXPERIMENTAL
Intervention: Ideal care for women veterans as articulated by local health leaders
Number of subjects: 86
Study 30455168 — intervention group
Group type: EXPERIMENTAL
Intervention: Teledialog Telerehabilitation Program
Number of subjects: 37
Study 30455171 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-based app for consent process
Number of subjects: 100
Study 30455171 — intervention group
Group type: COMPARATOR
Intervention: Standard practice consent process
Number of subjects: 100
Study 30455225 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular subsets characterized by translocations involving chimeric oncogenes
Number of subjects: 0
Study 30455340 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana exposure (COOH-THC)
Number of subjects: 0
Study 30455340 — intervention group
Group type: EXPERIMENTAL
Intervention: THC exposure
Number of subjects: 0
Study 30455340 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental marijuana use
Number of subjects: 0
Study 30455404 — intervention group
Group type: EXPERIMENTAL
Intervention: Early OAC (0-4 days)
Number of subjects: 1355
Study 30455404 — intervention group
Group type: COMPARATOR
Intervention: Late OAC (≥5 days or never started)
Number of subjects: 1355
Study 30455722 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 0
Study 30455964 — intervention group
Group type: EXPERIMENTAL
Intervention: mhGAP training of primary health care providers
Number of subjects: 36
Study 30455964 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mhGAP training)
Number of subjects: 36
Study 30456327 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Isoniazid with peer counseling
Number of subjects: 263
Study 30456327 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 263
Study 30457484 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual hepatic venous pressure gradient (HVPG)
Number of subjects: 102
Study 30457897 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 0
Study 30457897 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventana PD-L1 (SP263) assay
Number of subjects: 0
Study 30458511 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthesized images of animate and inanimate objects with matched curvilinear and rectilinear information, presented as texture patterns.
Number of subjects: 0
Study 30458511 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthesized images of animate and inanimate objects with no feedback given.
Number of subjects: 0
Study 30458511 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthesized images classified as animate.
Number of subjects: 0
Study 30458747 — intervention group
Group type: EXPERIMENTAL
Intervention: Phasix™ Mesh
Number of subjects: 85
Study 30459074 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher flavonoids intake (fifth quintile)
Number of subjects: 17065
Study 30459074 — intervention group
Group type: COMPARATOR
Intervention: Lowest quintile of flavonoids intake
Number of subjects: 17065
Study 30459098 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 20
Study 30459138 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers and Babies (MB) group intervention led by mental health professionals (MHPs)
Number of subjects: 933
Study 30459138 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers and Babies (MB) group intervention led by paraprofessional home visitors
Number of subjects: 933
Study 30459138 — intervention group
Group type: COMPARATOR
Intervention: Usual home visiting (HV) services
Number of subjects: 933
Study 30459144 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchful waiting
Number of subjects: 1500
Study 30459144 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical interventions
Number of subjects: 1500
Study 30459144 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural interventions
Number of subjects: 1500
Study 30459647 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 561
Study 30459647 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe depression subgroup (HAMD-17 ≥ 25)
Number of subjects: 561
Study 30459653 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-Based Addiction Rehabilitation Electronic System
Number of subjects: 0
Study 30460321 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezlotoxumab
Number of subjects: 0
Study 30460321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30460495 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystatin C (CysC) serum levels
Number of subjects: 2803
Study 30460518 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg bid (octogenarians)
Number of subjects: 80
Study 30460518 — intervention group
Group type: COMPARATOR
Intervention: Apixaban 2.5 mg bid (octogenarians with appropriately reduced dose)
Number of subjects: 80
Study 30460518 — intervention group
Group type: COMPARATOR
Intervention: Younger patients (age < 70 years)
Number of subjects: 80
Study 30460684 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixazomib 4 mg and cyclophosphamide 300 mg/m² with low-dose dexamethasone
Number of subjects: 0
Study 30460774 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score (GRS) comprising 15 single-nucleotide polymorphisms
Number of subjects: 920
Study 30460774 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 920
Study 30460857 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinhole glasses
Number of subjects: 32
Study 30461016 — intervention group
Group type: EXPERIMENTAL
Intervention: Keratinized mucosa (KM) band <2 mm
Number of subjects: 37
Study 30461016 — intervention group
Group type: COMPARATOR
Intervention: Keratinized mucosa (KM) band ≥2 mm
Number of subjects: 37
Study 30461016 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of peri-implantitis
Number of subjects: 37
Study 30461161 — intervention group
Group type: EXPERIMENTAL
Intervention: Caesarean section rates in 2007
Number of subjects: 34063
Study 30461161 — intervention group
Group type: EXPERIMENTAL
Intervention: Caesarean section rates in 2013
Number of subjects: 34063
Study 30461161 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipara whose labour was not induced or augmented in 2013
Number of subjects: 34063
Study 30461161 — intervention group
Group type: EXPERIMENTAL
Intervention: Nullipara whose labour was not induced or augmented
Number of subjects: 34063
Study 30461161 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple pregnancies in 2007
Number of subjects: 34063
Study 30461161 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple pregnancies in 2013
Number of subjects: 34063
Study 30461161 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall neonatal mortality in 2007
Number of subjects: 34063
Study 30461161 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall neonatal mortality in 2013
Number of subjects: 34063
Study 30461161 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal mortality in multiparous women whose labour was not induced or augmented in 2007
Number of subjects: 34063
Study 30461161 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal mortality in multiparous women whose labour was not induced or augmented in 2013
Number of subjects: 34063
Study 30461442 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarettes (number of cigarettes/day)
Number of subjects: 498
Study 30461442 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmedical prescription stimulants (NPS) (days of NPS use)
Number of subjects: 498
Study 30461441 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' perceptions about drug use behaviors among US adults
Number of subjects: 241
Study 30461441 — intervention group
Group type: EXPERIMENTAL
Intervention: Normative beliefs about contemporaneous patients in the heroin withdrawal program
Number of subjects: 241
Study 30461441 — intervention group
Group type: EXPERIMENTAL
Intervention: Normative perceptions
Number of subjects: 241
Study 30461641 — intervention group
Group type: EXPERIMENTAL
Intervention: ABSI (A body shape index)
Number of subjects: 2354
Study 30462243 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher outdoor temperature
Number of subjects: 222511
Study 30462243 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative humidity
Number of subjects: 222511
Study 30462243 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic-induced hyponatremia
Number of subjects: 222511
Study 30462244 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatinine-adjusted urinary concentrations of mono-2-ethylhexyl phthalate (MEHP)
Number of subjects: 209
Study 30462244 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatinine-adjusted urinary concentrations of mono-2-ethyl-5-oxohexyl phthalate (MEOHP)
Number of subjects: 209
Study 30462244 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatinine-adjusted urinary concentrations of mono-2-ethyl-5-hydroxyhexyl phthalate
Number of subjects: 209
Study 30462688 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) patients
Number of subjects: 362
Study 30462688 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional support
Number of subjects: 362
Study 30462688 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-distraction coping
Number of subjects: 362
Study 30462688 — intervention group
Group type: EXPERIMENTAL
Intervention: Internalized HIV/AIDS stigma
Number of subjects: 362
Study 30462688 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental support
Number of subjects: 362
Study 30462688 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral disengagement coping
Number of subjects: 362
Study 30462688 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental support by income
Number of subjects: 362
Study 30462688 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner status by age
Number of subjects: 362
Study 30463526 — intervention group
Group type: EXPERIMENTAL
Intervention: High OSA risk (41% of patients)
Number of subjects: 190
Study 30463526 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe insomnia symptoms (27% of patients)
Number of subjects: 190
Study 30463565 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine cardiovascular magnetic resonance (CMR) stress testing
Number of subjects: 327
Study 30463565 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial ischemia during dobutamine CMR testing
Number of subjects: 327
Study 30463844 — intervention group
Group type: EXPERIMENTAL
Intervention: Substitution studies (energy matched comparisons with other macronutrients)
Number of subjects: 5086
Study 30463844 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition studies (excess energy from sugars added to diets)
Number of subjects: 5086
Study 30463844 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum studies (sugars freely replaced by other macronutrients without control for energy)
Number of subjects: 5086
Study 30463844 — intervention group
Group type: EXPERIMENTAL
Intervention: Substitution studies
Number of subjects: 5086
Study 30463996 — intervention group
Group type: EXPERIMENTAL
Intervention: trastuzumab
Number of subjects: 0
Study 30464579 — intervention group
Group type: EXPERIMENTAL
Intervention: duloxetine 60 mg/day
Number of subjects: 353
Study 30464579 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 353
Study 30465166 — intervention group
Group type: EXPERIMENTAL
Intervention: C4B copy number
Number of subjects: 145
Study 30465184 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 797
Study 30465321 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE)
Number of subjects: 0
Study 30465637 — intervention group
Group type: EXPERIMENTAL
Intervention: CI532 slim modiolar electrode
Number of subjects: 44
Study 30466205 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright Light Therapy (BLT) administered in the morning for 10 weeks with dose escalation at 7.5, 10, 15, 30, and 45 minutes/day.
Number of subjects: 3
Study 30466205 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright Light Therapy (BLT) administered at mid-day for 10 weeks with dose escalation at 7.5, 10, 15, 30, and 45 minutes/day.
Number of subjects: 3
Study 30466205 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 1 week prior to randomization.
Number of subjects: 3
Study 30466410 — intervention group
Group type: EXPERIMENTAL
Intervention: Crizotinib (250 mg twice/day)
Number of subjects: 1
Study 30466435 — intervention group
Group type: EXPERIMENTAL
Intervention: Early dieters (first dieted by age 11y)
Number of subjects: 139
Study 30466435 — intervention group
Group type: EXPERIMENTAL
Intervention: Dieting behaviors (general)
Number of subjects: 139
Study 30466832 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolut R self-expanding transcatheter heart valve (THV)
Number of subjects: 1040
Study 30467013 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC) therapy initiated, monitored for biliary concentrations during the first 7 days.
Number of subjects: 41
Study 30467088 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine opt-out testing for hepatitis C virus
Number of subjects: 24567
Study 30467088 — intervention group
Group type: COMPARATOR
Intervention: Risk-based and one-time testing for individuals born between 1945 and 1965
Number of subjects: 24567
Study 30467088 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic infection among those tested positive
Number of subjects: 24567
Study 30467088 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver fibrosis assessment
Number of subjects: 24567
Study 30467135 — intervention group
Group type: EXPERIMENTAL
Intervention: Fesoterodine, administered over a treatment phase of 12 weeks (three cycles of 4 weeks each).
Number of subjects: 0
Study 30467135 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised questionnaires (AD symptoms and quality of life) and bladder and bowel diaries at the end of each treatment cycle.
Number of subjects: 0
Study 30467461 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain-computer interface (BCI) intervention
Number of subjects: 0
Study 30467461 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 30467660 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted intra-operative radiotherapy (IORT) with low-energy X-ray plus whole breast irradiation (WBI)
Number of subjects: 215
Study 30467678 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological morbidity prediction instrument at ICU discharge
Number of subjects: 572
Study 30467678 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms of depression
Number of subjects: 572
Study 30467678 — intervention group
Group type: EXPERIMENTAL
Intervention: Traumatic memories
Number of subjects: 572
Study 30467678 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of social support
Number of subjects: 572
Study 30467678 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 572
Study 30467678 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction instrument
Number of subjects: 572
Study 30467809 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mL methoxyflurane (self-administered via inhalation under supervision)
Number of subjects: 272
Study 30467809 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC) including IV morphine for severe pain (NRS ≥ 7); IV paracetamol or ketoprofen for moderate pain (NRS 4-6)
Number of subjects: 272
Study 30467809 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxyflurane
Number of subjects: 272
Study 30467809 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare professional-rated practicality of study treatment at 30 min after randomisation using a 5-point Likert scale
Number of subjects: 272
Study 30467809 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxyflurane and SoC
Number of subjects: 272
Study 30468137 — intervention group
Group type: EXPERIMENTAL
Intervention: TRD group
Number of subjects: 1148
Study 30468137 — intervention group
Group type: COMPARATOR
Intervention: TRD versus responders
Number of subjects: 1148
Study 30468137 — intervention group
Group type: COMPARATOR
Intervention: TRD versus responders and non-responders
Number of subjects: 1148
Study 30468243 — intervention group
Group type: EXPERIMENTAL
Intervention: PI3Kα inhibition
Number of subjects: 80
Study 30468243 — intervention group
Group type: EXPERIMENTAL
Intervention: PI3K-targeted drugs
Number of subjects: 80
Study 30470143 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients in bout (n=17)
Number of subjects: 43
Study 30470143 — intervention group
Group type: COMPARATOR
Intervention: Patients in remission (n=11)
Number of subjects: 43
Study 30470569 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-acting antiviral drugs for chronic hepatitis C
Number of subjects: 0
Study 30470580 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-release dimethyl fumarate (DMF) 240 mg BID
Number of subjects: 318
Study 30470662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine
Number of subjects: 0
Study 30470662 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo or standard treatment not specified)
Number of subjects: 0
Study 30471304 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant hypoallergenic fragments of birch pollen allergen Bet v 1
Number of subjects: 0
Study 30471345 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg ICG
Number of subjects: 45
Study 30471345 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg ICG
Number of subjects: 45
Study 30471345 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg ICG
Number of subjects: 45